drugset / Trial / NCT00427050
A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the optimal tolerated regime of PEP005 for the treatment of actinic keratoses of the face or face and scalp.
Timeline
- Start
- 2007-01
- Primary completion
- 2007-11
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ingenol mebutate | Small molecule | — | Topical |